Penserra Capital Management LLC Spectrum Pharmaceuticals Inc Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$1.27 - $2.42 $4,768 - $9,087	-3,755 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.15 - $3.82 $172 - $305	80 Added 2.18%	3,755 $8,000
Q2 2021 Aug 12, 2021	BUY	$2.89 - $4.45 $982 - $1,513	340 Added 10.19%	3,675 $13,000
Q1 2021 May 13, 2021	SELL	$2.9 - $4.09 $188 - $265	-65 Reduced 1.91%	3,335 $10,000
Q4 2020 Feb 12, 2021	BUY	$3.38 - $5.14 $7,280 - $11,071	2,154 Added 172.87%	3,400 $11,000
Q3 2020 Nov 13, 2020	BUY	$2.99 - $4.9 $3,725 - $6,105	1,246 New	1,246 $5,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.